Search results
Showing 961 to 975 of 1251 results for public health guidance
In development Reference number: GID-TA11449 Expected publication date: TBC
Discontinued Reference number: GID-TA11289
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [TSID12099]
In development Reference number: GID-TA11640 Expected publication date: TBC
In development Reference number: GID-TA11567 Expected publication date: TBC
In development Reference number: GID-TA11482 Expected publication date: TBC
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]
In development Reference number: GID-TA10886 Expected publication date: TBC
Discontinued Reference number: GID-TAG421
In development Reference number: GID-TA11831 Expected publication date: TBC
Opicapone for adjunctive treatment of motor signs and symptoms in Parkinson's disease [TSID11941]
In development Reference number: GID-TA11481 Expected publication date: TBC
Optical Coherence Tomography to guide percutaneous coronary intervention
In development Reference number: GID-IPG10394 Expected publication date: TBC
Gefurulimab for treating antibody-positive generalised myasthenia gravis [TSID12256]
In development Reference number: GID-TA11848 Expected publication date: TBC
New life-extending treatment given the green light for people with rare form of bile duct cancer
A new targeted treatment for a rare and aggressive form of bile duct cancer has been recommended by NICE for routine use on the NHS in England, giving people more time with better quality of life.
Discontinued Reference number: GID-NG10053
In development Reference number: GID-TA11844 Expected publication date: TBC
Discontinued Reference number: GID-NG10163